- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 277/40 - Unsubstituted amino or imino radicals
Patent holdings for IPC class C07D 277/40
Total number of patents in this class: 142
10-year publication summary
|
11
|
11
|
8
|
5
|
5
|
8
|
10
|
3
|
6
|
5
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Aldeyra Therapeutics, Inc. | 106 |
11 |
| Bayer Cropscience AG | 1983 |
5 |
| Oryzon Genomics S.A. | 108 |
5 |
| Allergan, Inc. | 2313 |
4 |
| Duke University | 3125 |
4 |
| The University of North Carolina at Chapel Hill | 2067 |
4 |
| The Board of Regents of the University of Texas System | 2234 |
4 |
| Immunesensor Therapeutics, Inc. | 35 |
4 |
| The Regents of the University of California | 20303 |
3 |
| City of Hope | 1013 |
3 |
| Medivir AB | 119 |
3 |
| Vivoryon Therapeutics N.V. | 45 |
3 |
| Centre National de La Recherche Scientifique | 10706 |
2 |
| Bayer Intellectual Property GmbH | 2454 |
2 |
| The Board of Trustees of the Leland Stanford Junior University | 6541 |
2 |
| Arcus Biosciences, Inc. | 144 |
2 |
| Atrogi AB | 59 |
2 |
| Board of Supervisors of Louisiana State University and Agricultural and Mechanical College | 824 |
2 |
| Egis Gyogyszergyar Rt. | 54 |
2 |
| Obschestvo S Ogranichennoi Otvetsttvennoctiyu "bionika" | 2 |
2 |
| Other owners | 73 |